Posted in | News | Plastics and Polymers

Dow to Shut 3 Emulsion Polymer Facilities

The Dow Emulsion Polymers Business has announced that it will permanently close three of its manufacturing facilities in King’s Lynn (United Kingdom), Varennes (Canada) and Pittsburg (United States). These facilities were already idled during the 2nd half of 2008 and were producing latex for the paper and carpet industry. After extensive analysis of the economic outlook and financial feasibility, it was decided not to re-start production at these facilities.

"This decision follows a thoughtful and prudent cost-benefit analysis taking into consideration the latex business and rapidly changing market conditions, such as the competitiveness of the raw material position, the small scale and the age of the facilities as well as the outlook for the global latex market," says Philippe Raynaud de Fitte, General Manager Dow Emulsion Polymers. "In combination these factors mean that the production of latex in the three impacted locations is no longer economically viable. However, with 14 production facilities worldwide, Dow Emulsion Polymers intends to remain a global leader in the latex industry."

After the idling of the assets, Dow was able to re-deploy most of the impacted employees within the company. The business will look at the most cost effective way to dispose of the assets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.